Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells

Srinivas Venkateswarlu, Dawn M. Dawson, Patricia St Clair, Anjana Gupta, James K.V. Willson, Michael G. Brattain

Research output: Contribution to journalArticlepeer-review

65 Scopus citations


The aim of this study was to determine whether constitutive ErbB2 activation controls growth and apoptosis in colon cancer cells. Growth arrested GEO cells showed constitutive activation of ErbB2 in the absence of exogenous growth factors or serum supplementation. Higher levels of heregulin and ErbB2 activation were observed in the growth-arrested state and cell cycle re-entry was independent of exogenous growth factors. Blockade of ErbB2 activation by heregulin neutralizing antibodies and by AG879 resulted in prevention of cell cycle re-entry. This indicated that autocrine heregulin activity was responsible for growth factor independence and for cell cycle re-entry. Activation of ErbB2 was the result of heregulin mediated interaction with ErbB3 and generated downstream activation of the ERK and the PI3K/AKT pathways. Heregulin neutralizing antibody treatment of growth arrested GEO cells also generated apoptosis as reflected by PARP cleavage and DNA fragmentation indicating a cell survival signal was also induced by the constitutively activated ErbB2. The activation of AKT but not the MAPK pathway was responsible for cell survival in these cells.

Original languageEnglish (US)
Pages (from-to)78-86
Number of pages9
Issue number1
StatePublished - Jan 3 2002
Externally publishedYes


  • Constitutive activation
  • Erbb2
  • Heregulin

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research


Dive into the research topics of 'Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells'. Together they form a unique fingerprint.

Cite this